Literature DB >> 13867863

Demethylchlortetracycline-induced fluorescence of gastric sediment. Use to differentiate benign and malignant gastric lesions.

J E BERK, S M KANTOR.   

Abstract

Entities:  

Keywords:  FLUORESCENCE; STOMACH NEOPLASMS/diagnosis; TETRACYCLINE/related compounds

Mesh:

Substances:

Year:  1962        PMID: 13867863     DOI: 10.1001/jama.1962.03050130001001

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  9 in total

1.  MEDICAL MANAGEMENT OF GASTRIC ULCER.

Authors:  R V DISERENS; F M BEMAN; C J DELOR
Journal:  Am J Dig Dis       Date:  1964-03

2.  [ANIMAL EXPERIMENTAL CONTRIBUTION TO THE PROBLEM OF TETRACYCLINE DEPOSITION IN THE TUMOR TISSUE].

Authors:  K ENGELBART; D GERICKE; A SOEDER
Journal:  Z Krebsforsch       Date:  1964-11-02

3.  ANNOTATIONS.

Authors: 
Journal:  Br Med J       Date:  1962-05-19

4.  [On malignancy diagnosis using the oxytetracycline-fluorescence test].

Authors:  H Schubert
Journal:  Arch Klin Exp Dermatol       Date:  1968

5.  [Tetracycline fluorescence in the diagnosis of lung cancer].

Authors:  J A Pilheu
Journal:  Beitr Klin Erforsch Tuberk Lungenkr       Date:  1969

6.  Tetracycline fluorescence and cytological procedures compared for the detection of malignancy.

Authors:  L J Sandlow; H Necheles
Journal:  Gut       Date:  1966-12       Impact factor: 23.059

7.  Cytological detection of stomach cancer.

Authors: 
Journal:  Br Med J       Date:  1966-06-11

8.  Critical evaluation of the tetracycline fluorescence test in the diagnosis of gastric carcinoma.

Authors:  G H WORSLEY; R D McKENNA
Journal:  Can Med Assoc J       Date:  1963-06-29       Impact factor: 8.262

9.  Tetracycline fluorescence in experimental tumours.

Authors:  E Tapp; R Carroll; K Kovács
Journal:  Br J Cancer       Date:  1965-09       Impact factor: 7.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.